Molekulárisan célzott biológiai terápia a szolid tumorok kezelésében - 1. Emlorák és colorectalis rák

Research output: Review article

2 Citations (Scopus)


Modern biological oncotherapy of solid tumours means targeting various kinase inhibitor pathways either by specific monoclonal antibodies against extracellular receptors or ligands (trastuzumab, cetuximab, panitumumab, bevacizumab) or by small molecular weight oral kinase inhibitors that interfere with intracellular signal transduction (imatinib, sunitinib, lapatinib, erlotinib, gefitinib, sorafenib). Here we review the clinical use of targeted biological agents in breast and colorectal cancer.

Original languageHungarian
Pages (from-to)565-570
Number of pages6
JournalLege Artis Medicinae
Issue number8-9
Publication statusPublished - szept. 1 2007



  • Biological oncotherapy
  • Breast cancer
  • Colorectal cancer
  • Targeted oncotherapy
  • Tyrosin kinase inhibition

ASJC Scopus subject areas

  • Medicine(all)

Cite this